On April 16, 2008, MonoGen, Inc. announced that it had closed on the previously announced equity capital bought deal private placement financing for an aggregate amount of $7.5 million, including the exercise of the underwriter's over-allotment option. GMP Securities L.P. was the underwriter for this financing.
MonoGen, Inc., headquartered in the Chicago area, is a medical device and diagnostics company providing high-quality and cost-effective cytological screening and diagnostic products to healthcare providers in the anatomic pathology industry.
GMP Securities was advised by a team from Fasken Martineau that included Rubin Rapuch, Georges Dubé and Karoline Kralka.